用户名:
密 码:
注册
|
忘记密码?
首 页
药品信息
药品检索
全部药品
适应症分类
热门药品
专利信息
专利检索
专利权人导航
专利权人分组导航
分类查询
IPC导航
热门检索
专利分析
概况
申请趋势分析
申请人分析
发明人分析
IPC分析
项目文档
项目
个人项目
文档
个人文档
企业文档
公共文档
标签
互动
特色功能
广州科技订制咨询
特色资讯
医药新闻
帮助中心
关于本软件
药品
文档
专利
新闻
所有专利
选择导航
专利权人导航
专利权人分组导航
分类导航
专利权人导航
MENDELL CO INC EDWARD [US](11)
专利信息
Translation Company
查询条件
展开筛选条件
[专利权人] 包含 'MENDELL CO INC EDWARD [US]'
[药品] 包含 'Nifedipine'
清空条件
查询
分析
排序
公开日
公开号
申请日
申请号
中文标题
英文标题
降序
升序
翻到页码
标题
标题2
专利权人
发明人
附图
摘要
摘要2
优先权号
IPC
专利类型
首页
1
2
尾页
共
11
条记录, 当前第1/2页。
公开号
公开日
申请号
申请日
1.
US6245356B1
2001/6/12
US20000498448
2000/2/4
专利标题
:Sustained release heterodisperse hydrogel systems-amorphous drugs
专利权人
:
MENDELL CO INC EDWARD [US]
;
Sustained release oral solid dosage forms comprising agglomerated particles of a therapeutically active medicament in amorphous form, a gelling agent, an ionizable gel strength enhancing agent and an inert diluent, as well as processes for preparing and using the same are disclosed. The sustained release oral solid dosage forms are useful in the treatment of hypertension in human patients.
2.
US6136343A
2000/10/24
US19980207298
1998/12/8
专利标题
:Sustained release heterodisperse hydrogel systems for insoluble drugs
专利权人
:
MENDELL CO INC EDWARD [US]
;
A sustained release pharmaceutical formulation includes a sustained release excipient including a gelling agent, an inert pharmaceutical diluent, an optional cationic cross-linking agent, and a medicament having moderate to poor solubility is disclosed. In certain embodiments, the sustained release excipient is granulated with a solution or suspension of a hydrophobic polymer in an amount effective to slow the hydration of the gelling agent when the formulation is exposed to an environmental flu...
3.
US6048548A
2000/4/11
US19980106438
1998/6/29
专利标题
:Sustained release heterodisperse hydrogel systems-amorphous drugs
专利权人
:
MENDELL CO INC EDWARD [US]
;
Sustained release oral solid dosage forms comprising agglomerated particles of a therapeutically active medicament in amorphous form, a gelling agent, an ionizable gel strength enhancing agent and an inert diluent, as well as processes for preparing and using the same are disclosed. The sustained release oral solid dosage forms are useful in the treatment of hypertension in human patients.
4.
US5958456A
1999/9/28
US19970886496
1997/7/1
专利标题
:Controlled release formulation (albuterol)
专利权人
:
MENDELL CO INC EDWARD [US]
;
A sustained release pharmaceutical formulation and methods of making and using the same are provided. The sustained release pharmaceutical formulation includes a sustained release excipient including a gelling agent, an inert pharmaceutical diluent, an optional hydrophobic material and/or hydrophobic coating, and a medicament for sustained oral administration.
5.
US5846563A
1998/12/8
US19970843573
1997/4/18
专利标题
:Sustained release heterodisperse hydrogel systems for insoluble drugs
专利权人
:
MENDELL CO INC EDWARD [US]
;
A sustained release pharmaceutical formulation includes a sustained release excipient including a gelling agent, an inert pharmaceutical diluent, an optional cationic cross-linking agent, and a medicament having moderate to poor solubility is disclosed. In certain embodiments, the sustained release excipient is granulated with a solution or suspension of a hydrophobic polymer in an amount effective to slow the hydration of the gelling agent when the formulation is exposed to an environmental flu...
6.
US5773025A
1998/6/30
US19960634295
1996/4/18
专利标题
:Sustained release heterodisperse hydrogel systems-amorphous drugs
专利权人
:
MENDELL CO INC EDWARD [US]
;
Sustained release oral solid dosage forms comprising agglomerated particles of a therapeutically active medicament in amorphous form, a gelling agent, an ionizable gel strength enhancing agent and an inert diluent, as well as processes for preparing and using the same are disclosed. The sustained release oral solid dosage forms are useful in the treatment of hypertension in human patients.
7.
US5667801A
1997/9/16
US19960651901
1996/5/21
专利标题
:Sustained release heterodisperse hydrogel systems for insoluble drugs
专利权人
:
MENDELL CO INC EDWARD [US]
;
A sustained release pharmaceutical formulation includes a sustained release excipient including a gelling agent, an inert pharmaceutical diluent, an optional cationic cross-linking agent, and a medicament having moderate to poor solubility is disclosed. In certain embodiments, the sustained release excipient is granulated with a solution or suspension of a hydrophobic polymer in an amount effective to slow the hydration of the gelling agent when the formulation is exposed to an environmental flu...
8.
US5662933A
1997/9/2
US19950553008
1995/11/3
专利标题
:Controlled release formulation (albuterol)
专利权人
:
MENDELL CO INC EDWARD [US]
;
A sustained release pharmaceutical formulation and methods of making and using the same are provided. The sustained release pharmaceutical formulation includes a sustained release excipient including a gelling agent, an inert pharmaceutical diluent, an optional hydrophobic material and/or hydrophobic coating, and a medicament for sustained oral administration.
9.
US5512297A
1996/4/30
US19950447235
1995/5/22
专利标题
:Sustained release heterodisperse hydrogel systems for insoluble drugs
专利权人
:
MENDELL CO INC EDWARD [US]
;
A sustained release pharmaceutical formulation includes a sustained release excipient including a gelling agent, an inert pharmaceutical diluent, an optional cationic cross-linking agent, and a medicament having moderate to poor solubility is disclosed. In certain embodiments, the sustained release excipient is granulated with a solution or suspension of a hydrophobic polymer in an amount effective to slow the hydration of the gelling agent when the formulation is exposed to an environmental flu...
10.
US5455046A
1995/10/3
US19930118924
1993/9/9
专利标题
:Sustained release heterodisperse hydrogel systems for insoluble drugs
专利权人
:
MENDELL CO INC EDWARD [US]
;
A sustained release pharmaceutical formulation includes a sustained release excipient including a gelling agent, an inert pharmaceutical diluent, an optional cationic cross-linking agent, and a medicament having moderate to poor solubility is disclosed. In certain embodiments, the sustained release excipient is granulated with a solution or suspension of a hydrophobic polymer in an amount effective to slow the hydration of the gelling agent when the formulation is exposed to an environmental flu...
首页
1
2
尾页
共
11
条记录, 当前第1/2页。
当前查询条件: [专利权人] 包含 'MENDELL CO INC EDWARD [US]'
AND
[药品] 包含 'Nifedipine'
查询范围
在当前结果中查询
!
专利类型
发明
实用新型
外观设计
!
公开号
CN1234
!
申请号
CN1234
!
专利标题
扩展
PHARMA
!
专利权人
扩展
pfizer
发明人
!
申请日
yyyymmdd
!
公开日
yyyymmdd
优先权号
!
摘要
扩展
PHARMA
IPC
A01B
下载范围
下载第
到
条记录。
下载内容
题录信息
专利全文